Linezolid May Outperform Vancomycin for MRSA Pneumonia Costs
A systematic review published in Cost Effectiveness and Resource Allocation indicates that linezolid is generally more cost-effective than vancomycin for ...
A systematic review published in Cost Effectiveness and Resource Allocation indicates that linezolid is generally more cost-effective than vancomycin for ...
A retrospective cohort study found preoperative Staphylococcus aureus screening was not independently associated with a significant reduction in surgical site ...
The pathogen was identified as the Panton–Valentine leukocidin (PVL)-positive ψUSA300 clone, a lineage increasingly associated with skin and soft tissue ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.